Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial).


AIM To evaluate the effectiveness of montelukast as add-on therapy for asthmatic patients who remain uncontrolled with low, moderate or high doses of inhaled corticosteroid monotherapy. DESIGN An eight-week, multicentre, open-label, observational study. RESULTS Of 320 patients enrolled, 288 (90.0%) completed the study. Of patients who had uncontrolled… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics